颖奕国际医疗
20人以下
公司优势
Hainan | YINGYI INTERNATIONAL MEDICAL CENTER
YINGYI INTERNATIONAL MEDICAL CENTER obtained the special medical practice access permit in Boao Lecheng International Medical Tourism Pilot Zone of Hainan Province in 2015. The construction of YINGYI INTERNATIONAL MEDICAL CENTER started in 2019. It is a third-level comprehensive hospital covering an area of 80 mu with a total construction area of 63,000 square meters. The hospital features a full-range human cell tissue storage library for cell sample freezing, a GTP-level thousand-grade cell preparation center, and a medical imaging center providing DR, MRI, CT, ultrasound, and other examinations, dedicated to offering customers more precise medical imaging diagnosis services. It is a modern new comprehensive treatment hospital with a precision medical molecular diagnosis laboratory, clean operating rooms of grade hundred, thousand, and ten thousand levels, and 300 beds. The main departments under construction in Phase I include sports medicine and rehabilitation center, preventive medicine center, health management center, anti-aging and medical aesthetics center, and chronic disease management center. The full-range human cell tissue storage library and cGMP-level cell preparation center, medical imaging center providing DR, MRI, CT, ultrasound, and testing center providing precision medical molecular detection, gene detection, proteomics detection, intestinal flora detection, functional medicine, and other detection services are committed to providing customers with more accurate medical diagnosis services. The main departments under construction in the first phase such as sports medicine department and rehabilitation center, tumor prevention and treatment center, anti-aging and medical aesthetics center, preventive medicine center, chronic disease management center, etc., are expected to open for business on February 1, 2021.
Global technology integration includes:
U.S. Caladrius Biosciences, Inc. (NASDAQ: CLBS)
U.S. Regenexx Corporate
U.S. CTABioman Biotechnology Group (NASDAQ: CBMG)
U.S. Aspire Lifestyles
U.S. Aspine Health Group
Germany TICEBA GmbH
South Korea Biosolution Co., Ltd
North America Cabo San Lucas Diamante
Taiwan Taipei Veterans General Hospital
China Medical University Affiliated Hospital
20,861+ 岗位更新等你来订阅
一键订阅最新的岗位，每周送达
🎉恭喜你，订阅成功
继续订阅您可以在邮箱中随时取消订阅
哈尔滨市博众泰达光学精密机械科技有限公司招聘英才
F.I.S.T. Science & Technology Corporation.
Company Profile
Kunming Hengruifeng Technology Co., Ltd. is a Sino-Canadian joint venture enterprise. Since its establishment, the company has been committed to the technological transformation and upgrading of China's traditional industries (mainly the tobacco industry), as well as the import and export of machinery and the development of instrument equipment.
Over the years, with high-quality products, advanced technology, timely supply, and fast and good after-sales service, the company has maintained close and in-depth communication with domestic leading tobacco enterprises such as Yunnan Hongta Group, Hongyun Honghe Group, and Shanghai Tobacco Group, and has been highly praised by customers for its positive and responsible work attitude.
At the same time, the company has established and maintained good cooperative relationships with several well-known European and American manufacturers of tobacco industry product equipment, supplying high-quality products and providing advanced technology and fast and good after-sales service to major domestic tobacco enterprises. While helping customers solve problems, it continuously enhances the company's influence and credibility.
Today's market is constantly changing and developing. To adapt to the diversification of the market and the specific needs of customers, Hengruifeng has been striving for innovation and self-improvement. Determined to reflect the company's business philosophy of integrity through leading technology, top-notch technical skills, superior quality, and comprehensive after-sales service, the company aims to achieve a shared bright future with its customers.
Address: Room 2407, Construction Building, No. 36 Dongfeng East Road, Kunming.
成立于2019年的云南云之鹊酒业有限公司，其创始团队凭借长达20余年的国内顶级酒水运营与市场管理经验，自成立以来始终坚持将消费者利益置于首位，专注于为消费者提供卓越品质的瓶装白酒。
公司在战略指引下，创新性地在云南地区推出了“真老酒”系列，旨在酿造出云南最优质的白酒，追求打造云南白酒的巅峰之作。旗下所有产品均沿用当地流传400多年的传统酿酒技艺，确保每一滴酒都蕴含着深厚的历史底蕴和独特的风味。
为了确保产品的高质量与独特风味，公司精选与名酒同等级的高粱作为主要原料，并精心配比高品质酒曲，力求在保留传统工艺精髓的同时，进一步提升酒品的口感与层次。此外，公司还聘请了由国家白酒专业评委、国家一级品酒师与调酒师组成的顶级大师团队作为技术顾问，以确保产品的品质达到行业顶尖水平。
当前，公司的核心产品“红喜鹊”、“小喜鹊”、“蓝喜鹊”与“金喜鹊”均以陈年老酒为基酒，分别拥有3年以上与6-12年以上的窖藏时间，这些酒款以其清新的香气、醇厚的口感、细腻的回味等特点，赢得了广泛赞誉。其中，“金喜鹊”与“蓝喜鹊”两款产品更是在国际烈酒大赛中连续摘得金牌，为云南白酒树立了新的标杆，改变了云南过去仅有优质烟草而缺乏佳酿的历史。
自上市以来，云南云之鹊酒业有限公司的产品不仅在云南省内广受欢迎，更在全国范围内取得了不俗的销售业绩，赢得了广大消费者的喜爱与好评。
公司员工都非常友善，大家互相帮助，欢迎你加入我们。
我们是一家新兴的影视传媒公司，一切都充满新鲜感！